Iranian Journal of Psychiatry and Behavioral Sciences

Published by: Kowsar

Short-term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia

Mehryar Nader-Mohammadi Moghadam 1 , Mohammad-Kazem Atef-Vahid 1 , * , Ali-Asghar Asgharnejad-Farid 1 , Amir Shabani 1 and Fahimeh Lavasni 1
Authors Information
1 Tehran Institute of Psychiatry, Tehran University of Medical Sciences Tehran, IR Iran
Article information
  • Iranian Journal of Psychiatry and Behavioral Sciences: June 28, 2015, 9 (2)
  • Published Online: June 8, 2015
  • Article Type: Original Article
  • Received: October 25, 2014
  • Revised: November 22, 2014
  • Accepted: February 7, 2015
  • DOI: 10.17795/ijpbs228

To Cite: Nader-Mohammadi Moghadam M, Atef-Vahid M, Asgharnejad-Farid A, Shabani A, Lavasni F. Short-term Dynamic Psychotherapy versus Sertraline in Treatment of Social Phobia, Iran J Psychiatry Behav Sci. 2015 ; 9(2):-. doi: 10.17795/ijpbs228.

Copyright © 2015, Mazandaran University of Medical Sciences.This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Lang AJ, Stein MB. Social phobia: prevalence and diagnostic threshold. J Clin Psychiatry. 2001; 62 Suppl 1: 5-10[PubMed]
  • 2. Schneier FR, Johnson J, Hornig CD, Liebowitz MR, Weissman MM. Social phobia. Comorbidity and morbidity in an epidemiologic sample. Arch Gen Psychiatry. 1992; 49(4): 282-8[PubMed]
  • 3. Magee WJ, Eaton WW, Wittchen HU, McGonagle KA, Kessler RC. Agoraphobia, simple phobia, and social phobia in the National Comorbidity Survey. Arch Gen Psychiatry. 1996; 53(2): 159-68[PubMed]
  • 4. Wittchen HU, Fehm L. Epidemiology, patterns of comorbidity, and associated disabilities of social phobia. Psychiatr Clin North Am. 2001; 24(4): 617-41[PubMed]
  • 5. Westenberg HG. The nature of social anxiety disorder. J Clin Psychiatry. 1998; 59 Suppl 17: 20-6[PubMed]
  • 6. Yonkers KA, Dyck IR, Keller MB. An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and women. Psychiatr Serv. 2001; 52(5): 637-43[PubMed]
  • 7. Beidel DC. Social anxiety disorder: etiology and early clinical presentation. J Clin Psychiatry. 1998; 59 Suppl 17: 27-32[PubMed]
  • 8. Turner SM, Beidel DC, Townsley RM. Social phobia: a comparison of specific and generalized subtypes and avoidant personality disorder. J Abnorm Psychol. 1992; 101(2): 326-31[PubMed]
  • 9. Thyer BA, Parrish RT, Curtis GC, Nesse RM, Cameron OG. Ages of onset of DSM-III anxiety disorders. Compr Psychiatry. 1985; 26(2): 113-22[PubMed]
  • 10. Chartier MJ, Hazen AL, Stein MB. Lifetime patterns of social phobia: a retrospective study of the course of social phobia in a nonclinical population. Depress Anxiety. 1998; 7(3): 113-21[PubMed]
  • 11. Davidson JR, Hughes DL, George LK, Blazer DG. The epidemiology of social phobia: findings from the Duke Epidemiological Catchment Area Study. Psychol Med. 1993; 23(3): 709-18[PubMed]
  • 12. Versiani M, Amrein R, Montgomery SA. Social phobia: long-term treatment outcome and prediction of response--a moclobemide study. Int Clin Psychopharmacol. 1997; 12(5): 239-54[PubMed]
  • 13. Massion AO, Dyck IR, Shea MT, Phillips KA, Warshaw MG, Keller MB. Personality disorders and time to remission in generalized anxiety disorder, social phobia, and panic disorder. Arch Gen Psychiatry. 2002; 59(5): 434-40[PubMed]
  • 14. Merikangas KR, Angst J. Comorbidity and social phobia: evidence from clinical, epidemiologic, and genetic studies. Eur Arch Psychiatry Clin Neurosci. 1995; 244(6): 297-303[PubMed]
  • 15. Lecrubier Y, Weiller E. Comorbidities in social phobia. Int Clin Psychopharmacol. 1997; 12 Suppl 6-21[PubMed]
  • 16. Wittchen HU, Beloch E. The impact of social phobia on quality of life. Int Clin Psychopharmacol. 1996; 11 Suppl 3: 15-23[PubMed]
  • 17. Lipsitz JD, Schneier FR. Social phobia. Epidemiology and cost of illness. Pharmacoeconomics. 2000; 18(1): 23-32[PubMed]
  • 18. Weiller E, Bisserbe JC, Boyer P, Lepine JP, Lecrubier Y. Social phobia in general health care: an unrecognised undertreated disabling disorder. Br J Psychiatry. 1996; 168(2): 169-74[PubMed]
  • 19. Acarturk C, Smit F, de Graaf R, van Straten A, Ten Have M, Cuijpers P. Economic costs of social phobia: a population-based study. J Affect Disord. 2009; 115(3): 421-9[DOI][PubMed]
  • 20. Blanco C, Nissenson K, Liebowitz MR. Social anxiety disorder: recent findings in the areas of epidemiology, etiology, and treatment. Curr Psychiatry Rep. 2001; 3(4): 273-80[PubMed]
  • 21. Davidson JR. Pharmacotherapy of social phobia. Acta Psychiatr Scand Suppl. 2003; (417): 65-71[PubMed]
  • 22. Gould RA, Buckminster S, Pollack MH, Otto MW, Massachusetts LY. Cognitive-Behavioral and Pharmacological Treatment for Social Phobia: A Meta-Analysis. Clin Psychol: Sci Practice. 1997; 4(4): 291-306[DOI]
  • 23. Turner SM, Beidel DC, Jacob RG. Social phobia: a comparison of behavior therapy and atenolol. J Consult Clin Psychol. 1994; 62(2): 350-8[PubMed]
  • 24. Sadock BJ, Sadock VA. Kaplan and Sadock's synopsis of psychiatry: Behavioral sciences/clinical psychiatry. 2007;
  • 25. Van Ameringen MA, Lane RM, Walker JR, Bowen RC, Chokka PR, Goldner EM, et al. Sertraline treatment of generalized social phobia: a 20-week, double-blind, placebo-controlled study. Am J Psychiatry. 2001; 158(2): 275-81[PubMed]
  • 26. Haug TT, Hellstrom K, Blomhoff S, Humble M, Madsbu HP, Wold JE. The treatment of social phobia in general practice. is exposure therapy feasible? Fam Pract. 2000; 17(2): 114-8[PubMed]
  • 27. Katzelnick DJ, Kobak KA, Greist JH, Jefferson JW, Mantle JM, Serlin RC. Sertraline for social phobia: a double-blind, placebo-controlled crossover study. Am J Psychiatry. 1995; 152(9): 1368-71[PubMed]
  • 28. Munjack DJ, Flowers C, Eagan TV. Sertraline in social phobia. Anxiety. 1994; 1(4): 196-8[PubMed]
  • 29. Czepowicz VD, Johnson MR, Lydiard RB, Emmanuel NP, Ware MR, Mintzer OB, et al. Sertraline in social phobia. J Clin Psychopharmacol. 1995; 15(5): 372-3[PubMed]
  • 30. Rapee RM. Group treatment of children with anxiety disorders: Outcome and predictors of treatment response. Aust J Psychol. 2000; 52(3): 125-9[DOI]
  • 31. Zaider TI, Heimberg RG. Non-pharmacologic treatments for social anxiety disorder. Acta Psychiatr Scand Suppl. 2003; (417): 72-84[PubMed]
  • 32. Davidson JR, Foa EB, Huppert JD, Keefe FJ, Franklin ME, Compton JS, et al. Fluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia. Arch Gen Psychiatry. 2004; 61(10): 1005-13[DOI][PubMed]
  • 33. Alstrom JE, Nordlund CL, Persson G, Harding M, Ljungqvist C. Effects of four treatment methods on social phobic patients not suitable for insight-oriented psychotherapy. Acta Psychiatr Scand. 1984; 70(2): 97-110[PubMed]
  • 34. Fonagy P, Roth A, Higgitt A. Psychodynamic psychotherapies: evidence-based practice and clinical wisdom. Bull Menninger Clin. 2005; 69(1): 1-58[DOI][PubMed]
  • 35. Gabbard G, Levy RA, Ablon JS. Handbook of evidence-based psychodynamic psychotherapy: Bridging the gap between science and practice. 2008;
  • 36. Vaillant LMC. Changing character: Short-term anxiety-regulating psychotherapy for restructuring defenses, affects, and attachment. 1997;
  • 37. McCullough L, Kuhn N, Andrews S, Kaplan A, Wolf J, Hurley CL. Treating affect phobia: A manual for short-term dynamic psychotherapy. 2003;
  • 38. Svartberg M, Stiles TC, Seltzer MH. Randomized, controlled trial of the effectiveness of short-term dynamic psychotherapy and cognitive therapy for cluster C personality disorders. Am J Psychiatry. 2004; 161(5): 810-7[PubMed]
  • 39. Winston A, Laikin M, Pollack J, Samstag LW, McCullough L, Muran JC. Short-term psychotherapy of personality disorders. Am J Psychiatry. 1994; 151(2): 190-4[DOI][PubMed]
  • 40. Dehghani M, Atef-Vahid MK, Gharaee B. Efficacy of short-term anxiety-regulating psychotherapy on love trauma syndrome. Iran J Psychiatry Behav Sci. 2011; 5(2): 18-25[PubMed]
  • 41. Dornelas EA, Ferrand J, Stepnowski R, Barbagallo J, McCullough L. A pilot study of affect-focused psychotherapy for antepartum depression. J Psychother Integr. 2010; 20(4): 364
  • 42. First M, Spitzer R, Gibbon M, Williams J. Structured clinical interview for Axis I DSM-IV disorders. 1994;
  • 43. Connor KM, Davidson JR, Churchill LE, Sherwood A, Foa E, Weisler RH. Psychometric properties of the Social Phobia Inventory (SPIN). New self-rating scale. Br J Psychiatry. 2000; 176: 379-86[PubMed]
  • 44. Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR. Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychol Med. 2003; 33(4): 611-22[PubMed]
  • 45. Startup M, Jackson MC, Bendix S. The concurrent validity of the Global Assessment of Functioning (GAF). Br J Clin Psychol. 2002; 41: 417-22[PubMed]
  • 46. Bandelow B. Defining response and remission in anxiety disorders: toward an integrated approach. CNS Spectr. 2006; 11(10 Suppl 12): 21-8[PubMed]
  • 47. Bogels SM, Voncken MJ, de Vries K. Interpretation and judgmental biases in social phobia. Behav Res Ther. 2003; 41(12): 1481-8[PubMed]
  • 48. Crits-Christoph P. The efficacy of brief dynamic psychotherapy: a meta-analysis. Am J Psychiatry. 1992; 149(2): 151-8[PubMed]
  • 49. Leichsenring F, Rabung S, Leibing E. The efficacy of short-term psychodynamic psychotherapy in specific psychiatric disorders: a meta-analysis. Arch Gen Psychiatry. 2004; 61(12): 1208-16[DOI][PubMed]
  • 50. Leichsenring F, Leibing E. Psychodynamic psychotherapy: a systematic review of techniques, indications and empirical evidence. Psychol Psychother. 2007; 80: 217-28[DOI][PubMed]
  • 51. Lewis AJ, Dennerstein M, Gibbs PM. Short-term psychodynamic psychotherapy: review of recent process and outcome studies. Aust N Z J Psychiatry. 2008; 42(6): 445-55[DOI][PubMed]
  • 52. Knekt P, Lindfors O, Laaksonen MA, Renlund C, Haaramo P, Harkanen T, et al. Quasi-experimental study on the effectiveness of psychoanalysis, long-term and short-term psychotherapy on psychiatric symptoms, work ability and functional capacity during a 5-year follow-up. J Affect Disord. 2011; 132(1-2): 37-47[DOI][PubMed]
  • 53. Knijnik DZ, Blanco C, Salum GA, Moraes CU, Mombach C, Almeida E, et al. A pilot study of clonazepam versus psychodynamic group therapy plus clonazepam in the treatment of generalized social anxiety disorder. Eur Psychiatry. 2008; 23(8): 567-74[DOI][PubMed]
  • 54. Bressi C, Porcellana M, Marinaccio PM, Nocito EP, Magri L. Short-term psychodynamic psychotherapy versus treatment as usual for depressive and anxiety disorders: a randomized clinical trial of efficacy. J Nerv Ment Dis. 2010; 198(9): 647-52[DOI][PubMed]
  • 55. Abbass AA, Hancock JT, Henderson J, Kisely S. Short-term psychodynamic psychotherapies for common mental disorders. Cochrane Database Syst Rev. 2006; (4)[DOI][PubMed]
  • 56. Anderson EM, Lambert MJ. Short-term dynamically oriented psychotherapy: A review and meta-analysis. Clin Psychol Rev. 1995; 15(6): 503-14
  • 57. Liebowitz MR, DeMartinis NA, Weihs K, Londborg PD, Smith WT, Chung H, et al. Efficacy of sertraline in severe generalized social anxiety disorder: results of a double-blind, placebo-controlled study. J Clin Psychiatry. 2003; 64(7): 785-92[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments